Bioavailability, Pharmacokinetics, and Safety of Belimumab Administered Subcutaneously in Healthy Subjects

E-ISSN： 2160-7648|2|4|349-357

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.2, Iss.4, 2013-10, pp. : 349-357

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Relative Bioavailability of a Single Dose of Belimumab Administered Subcutaneously by Prefilled Syringe or Autoinjector in Healthy Subjects

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 3, 2016-05 ,pp. : 208-215

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety, bioavailability, and pharmacokinetics of VGX‐1027—A novel oral anti‐inflammatory drug in healthy human subjects

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 2, 2016-03 ,pp. : 91-101

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics and comparative bioavailability of domperidone suspension and tablet formulations in healthy adult subjects

Clinical Pharmacology In Drug Development, Vol. 3, Iss. 2, 2014-03 ,pp. : 126-131

John Wiley & Sons Inc

Access to resources Recommend Favorite

Bioavailability and Safety of the Factor Xa Inhibitor Edoxaban and the Effects of Quinidine in Healthy Subjects

Clinical Pharmacology In Drug Development, Vol. 2, Iss. 4, 2013-10 ,pp. : 358-366

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics and Safety of Ebastine in Healthy Subjects and Patients with Renal Impairment

By Noveck Robert J.

Clinical Pharmacokinetics, Vol. 46, Iss. 6, 2007-01 ,pp. : 525-534

Adis International

Access to resources Recommend Favorite